Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA2016 TriazavirinSummary: Triazavirin is a nucleoside analog of a nucleic acid and an antiviral agent. -
BA2017 3-DeoxysappanchalconeSummary: 3-Deoxysappanchalcone is a naturally occurring chalcone compound isolated from a leguminous plant with anti-allergic, anti-viral, anti-inflammatory and antioxidant activities. -
BA2018 S119-8Summary: S119-8 is a broad-spectrum inhibitor of influenza A and B viruses. -
BA2019 JNJ4796Summary: JNJ4796 is an orally active fusion inhibitor that neutralizes influenza A virus by inhibiting mediated fusion. -
BA2021 UmifenovirSummary: Umifenovir is a potent orally active broad-spectrum antiviral active molecule with activity against many enveloped and non-enveloped viruses. -
BA2022 DiridavumabSummary: Diridavumab is a monoclonal anti-HA stem antibody. -
BA2023 DL-GoitrinSummary: DL-Goitrin, also known as (R,S)-Guyichun, consists of epigoitrin (R-Guyichun) and guyichun (S-Guyichun). -
BA2024 LesofavumabSummary: A human IgG1κ anti-antibody. -
BA2025 Asp-Asp-Asp-Asp-Asp-AspSummary: Asp-Asp-Asp-Asp-Asp-Asp-Asp is a polyaspartic acid. -
BA2026 IHVR-17028Summary: IHVR-17028 is a potent broad-spectrum antiviral active molecule.

